Corporate Information | Press & Media | For Investors

ThinkGenetic

ThinkGenetic

Finding Patients At Risk for Rare Disease

  • Home
  • Solutions
    • FindEHR™
    • FindSM™
  • Research
    • Medical Publications
    • Technical Research
  • About
    • Team
    • Board
    • Partners
  • News & Events
  • Contact
  • Request a Demo

ThinkGenetic Announces Participation at 19th Annual WORLDSymposium™ 2023

By Ruth O'Keefe, Feb 8, 2023

ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited. The WORLDSymposium™ is an annual research conference dedicated to lysosomal diseases and will be taking place in Orlando, Florida February 22 – 26, 2023.

This symposium is designed for basic, translational, and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances. The session will be a LIVE in-person gathering in Orlando at the Hilton Orlando Hotel. In addition, plans are also underway to make the program available ON DEMAND after the conference ends to allow for registration for those who are unable to attend in person.”

Other ThinkGenetic team members in attendance at WORLD will include:

  • Cian Robinson – Chief Revenue Officer
  • Carol, Ogg, BS Pharm – VP of Business Development

Members of the leadership team continue to participate in this annual event for its important research presentations and to meet with key decision-makers to discuss potential partnership opportunities.

Interested in scheduling a meeting with ThinkGenetic at the WORLDSymposium? 

Contact us to learn more

Panel Presentation at Satellite Symposia

Date and Time: Thursday, February 23, 2023, 5:15 PM – 6:15 PM EST

Title: Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine

Panel includes: 

  • Dawn Laney, MS, CGC, CCRC – Emory University School of Medicine
  • Charlotte Hobbs, MD, PhD –  Rady Children’s Institute for Genomic Medicine
  • Melissa Wasserstein, MD – The Children’s Hospital at Montefiore and the Albert Einstein College of Medicine

Sponsor: Takeda Pharmaceutical Company Limited

Takeda approved the release of this communication on 2023-Feb-08.

About Ruth O’Keefe

Ruth anticipates and manages ThinkGenetic's marketing needs in a dynamic environment. She maintains strong engagement with clients and healthcare providers to further the ThinkGenetic mission.

News Dawn Laney, lysosomal diseases, Takeda, Takeda Pharmaceutical Company Limited, WORLDSymposium

Upcoming Events

Oct 17
October 17 - October 21

NSGC Annual Conference 2023

Feb 4
February 4, 2024 - February 9, 2024

WORLDSymposium on Lysosomal Disease Research 2024

Mar 12
March 12, 2024 - March 16, 2024

ACMG Annual Clinical Genetics Meeting 2024

Feb 2
February 2, 2025 - February 7, 2025

WORLDSymposium on Lysosomal Disease Research 2025

Mar 18
March 18, 2025 - March 22, 2025

ACMG Annual Clinical Genetics Meeting 2025

View Calendar

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

  • Solutions
    • FindEHR™
    • FindSM™
  • Resources
    • Contact
    • Research
    • FAQs
  • About ThinkGenetic
    • Team
    • Board
    • Investors
    • Careers
  • Legal
    • Disclaimers
    • Privacy Policy

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

©2023 ThinkGenetic. All Rights Reserved.